Barclays lowered the firm’s price target on ZoomInfo to $15 from $19 and keeps an Equal Weight rating on the shares. The company beat Q1 estimates verses low expectations, though the Q2 and lowered fiscal year outlook illustrate that the company is “not through the rough just yet,” the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ZI: